UniProt ID | KIF4A_HUMAN | |
---|---|---|
UniProt AC | O95239 | |
Protein Name | Chromosome-associated kinesin KIF4A | |
Gene Name | KIF4A | |
Organism | Homo sapiens (Human). | |
Sequence Length | 1232 | |
Subcellular Localization | Nucleus matrix. Cytoplasm, cytoskeleton, spindle. Midbody. Chromosome. Not present in the nucleolus. In early mitosis, associated with the mitotic spindle, in anaphase, localized to the spindle midzone and, in telophase and cytokinesis, to the midbod | |
Protein Description | Motor protein that translocates PRC1 to the plus ends of interdigitating spindle microtubules during the metaphase to anaphase transition, an essential step for the formation of an organized central spindle midzone and midbody and for successful cytokinesis. May play a role in mitotic chromosomal positioning and bipolar spindle stabilization.. | |
Protein Sequence | MKEEVKGIPVRVALRCRPLVPKEISEGCQMCLSFVPGEPQVVVGTDKSFTYDFVFDPSTEQEEVFNTAVAPLIKGVFKGYNATVLAYGQTGSGKTYSMGGAYTAEQENEPTVGVIPRVIQLLFKEIDKKSDFEFTLKVSYLEIYNEEILDLLCPSREKAQINIREDPKEGIKIVGLTEKTVLVALDTVSCLEQGNNSRTVASTAMNSQSSRSHAIFTISLEQRKKSDKNSSFRSKLHLVDLAGSERQKKTKAEGDRLKEGININRGLLCLGNVISALGDDKKGGFVPYRDSKLTRLLQDSLGGNSHTLMIACVSPADSNLEETLNTLRYADRARKIKNKPIVNIDPQTAELNHLKQQVQQLQVLLLQAHGGTLPGSITVEPSENLQSLMEKNQSLVEENEKLSRGLSEAAGQTAQMLERIILTEQANEKMNAKLEELRQHAACKLDLQKLVETLEDQELKENVEIICNLQQLITQLSDETVACMAAAIDTAVEQEAQVETSPETSRSSDAFTTQHALRQAQMSKELVELNKALALKEALARKMTQNDSQLQPIQYQYQDNIKELELEVINLQKEKEELVLELQTAKKDANQAKLSERRRKRLQELEGQIADLKKKLNEQSKLLKLKESTERTVSKLNQEIRMMKNQRVQLMRQMKEDAEKFRQWKQKKDKEVIQLKERDRKRQYELLKLERNFQKQSNVLRRKTEEAAAANKRLKDALQKQREVADKRKETQSRGMEGTAARVKNWLGNEIEVMVSTEEAKRHLNDLLEDRKILAQDVAQLKEKKESGENPPPKLRRRTFSLTEVRGQVSESEDSITKQIESLETEMEFRSAQIADLQQKLLDAESEDRPKQRWENIATILEAKCALKYLIGELVSSKIQVSKLESSLKQSKTSCADMQKMLFEERNHFAEIETELQAELVRMEQQHQEKVLYLLSQLQQSQMAEKQLEESVSEKEQQLLSTLKCQDEELEKMREVCEQNQQLLRENEIIKQKLTLLQVASRQKHLPKDTLLSPDSSFEYVPPKPKPSRVKEKFLEQSMDIEDLKYCSEHSVNEHEDGDGDDDEGDDEEWKPTKLVKVSRKNIQGCSCKGWCGNKQCGCRKQKSDCGVDCCCDPTKCRNRQQGKDSLGTVERTQDSEGSFKLEDPTEVTPGLSFFNPVCATPNSKILKEMCDVEQVLSKKTPPAPSPFDLPELKHVATEYQENKAPGKKKKRALASNTSFFSGCSPIEEEAH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
78 | Acetylation | PLIKGVFKGYNATVL HHHHHHHCCCCEEEE | 59.07 | 26051181 | |
129 | Ubiquitination | LFKEIDKKSDFEFTL HHHHHCCCCCCEEEE | 52.05 | - | |
158 | Ubiquitination | LLCPSREKAQINIRE HHCCCHHHHCCCCCC | 44.47 | - | |
172 | Ubiquitination | EDPKEGIKIVGLTEK CCCCCCEEEEECCCC | 42.04 | - | |
180 | Phosphorylation | IVGLTEKTVLVALDT EEECCCCEEEEEEEH | 16.91 | 30377224 | |
187 | Phosphorylation | TVLVALDTVSCLEQG EEEEEEEHHHHHHCC | 18.37 | 30377224 | |
189 | Phosphorylation | LVALDTVSCLEQGNN EEEEEHHHHHHCCCC | 18.31 | 30377224 | |
197 | Phosphorylation | CLEQGNNSRTVASTA HHHCCCCCHHHHHHH | 33.07 | 30377224 | |
199 | Phosphorylation | EQGNNSRTVASTAMN HCCCCCHHHHHHHCC | 21.90 | 30377224 | |
203 | Phosphorylation | NSRTVASTAMNSQSS CCHHHHHHHCCCCCC | 21.86 | - | |
207 | Phosphorylation | VASTAMNSQSSRSHA HHHHHCCCCCCCCEE | 20.53 | 27732954 | |
209 | Phosphorylation | STAMNSQSSRSHAIF HHHCCCCCCCCEEEE | 27.78 | 27732954 | |
210 | Phosphorylation | TAMNSQSSRSHAIFT HHCCCCCCCCEEEEE | 30.11 | 27732954 | |
234 | Phosphorylation | DKNSSFRSKLHLVDL CCCCCHHHHHHHHHH | 37.24 | 24719451 | |
235 | Ubiquitination | KNSSFRSKLHLVDLA CCCCHHHHHHHHHHC | 35.35 | - | |
244 | Phosphorylation | HLVDLAGSERQKKTK HHHHHCCCHHHHCCC | 24.81 | - | |
250 | Phosphorylation | GSERQKKTKAEGDRL CCHHHHCCCCCCCHH | 42.39 | 23403867 | |
251 | Ubiquitination | SERQKKTKAEGDRLK CHHHHCCCCCCCHHH | 54.01 | - | |
258 | Ubiquitination | KAEGDRLKEGININR CCCCCHHHHCCCCCC | 55.58 | - | |
269 | Glutathionylation | NINRGLLCLGNVISA CCCCHHHHHHHHHHH | 5.71 | 22555962 | |
281 | Acetylation | ISALGDDKKGGFVPY HHHCCCCCCCCCCCC | 59.04 | 25953088 | |
282 | Acetylation | SALGDDKKGGFVPYR HHCCCCCCCCCCCCC | 71.86 | 26051181 | |
288 | Phosphorylation | KKGGFVPYRDSKLTR CCCCCCCCCCCHHHH | 23.04 | 20068231 | |
291 | Phosphorylation | GFVPYRDSKLTRLLQ CCCCCCCCHHHHHHH | 22.14 | 20068231 | |
292 | Ubiquitination | FVPYRDSKLTRLLQD CCCCCCCHHHHHHHH | 59.16 | - | |
294 | Phosphorylation | PYRDSKLTRLLQDSL CCCCCHHHHHHHHHC | 24.02 | 20068231 | |
339 | Acetylation | RARKIKNKPIVNIDP HHHHHCCCCCCCCCH | 30.99 | 26051181 | |
394 | Phosphorylation | SLMEKNQSLVEENEK HHHHHCHHHHHHHHH | 43.72 | 29255136 | |
401 | Sumoylation | SLVEENEKLSRGLSE HHHHHHHHHHHHHHH | 64.44 | - | |
401 | Acetylation | SLVEENEKLSRGLSE HHHHHHHHHHHHHHH | 64.44 | 26051181 | |
401 | Sumoylation | SLVEENEKLSRGLSE HHHHHHHHHHHHHHH | 64.44 | - | |
401 | Ubiquitination | SLVEENEKLSRGLSE HHHHHHHHHHHHHHH | 64.44 | - | |
407 | Phosphorylation | EKLSRGLSEAAGQTA HHHHHHHHHHHHHHH | 28.19 | 22067460 | |
423 | Phosphorylation | MLERIILTEQANEKM HHHHHHHHHHHHHHH | 18.68 | - | |
429 | Ubiquitination | LTEQANEKMNAKLEE HHHHHHHHHHHHHHH | 36.94 | - | |
433 | Ubiquitination | ANEKMNAKLEELRQH HHHHHHHHHHHHHHH | 51.97 | - | |
444 | Ubiquitination | LRQHAACKLDLQKLV HHHHHHHHHHHHHHH | 40.07 | - | |
449 | Ubiquitination | ACKLDLQKLVETLED HHHHHHHHHHHHHCH | 62.89 | - | |
460 | Sumoylation | TLEDQELKENVEIIC HHCHHHHHHHHHHHH | 46.63 | - | |
474 | Phosphorylation | CNLQQLITQLSDETV HHHHHHHHHCCHHHH | 31.86 | 17081983 | |
490 | Phosphorylation | CMAAAIDTAVEQEAQ HHHHHHHHHHHHHHH | 26.87 | 17081983 | |
500 | Phosphorylation | EQEAQVETSPETSRS HHHHHHCCCCCCCCC | 51.21 | 26074081 | |
501 | Phosphorylation | QEAQVETSPETSRSS HHHHHCCCCCCCCCC | 13.77 | 26074081 | |
504 | Phosphorylation | QVETSPETSRSSDAF HHCCCCCCCCCCCCH | 32.59 | 26074081 | |
505 | Phosphorylation | VETSPETSRSSDAFT HCCCCCCCCCCCCHH | 28.62 | 26074081 | |
507 | Phosphorylation | TSPETSRSSDAFTTQ CCCCCCCCCCCHHHH | 32.13 | 30266825 | |
508 | Phosphorylation | SPETSRSSDAFTTQH CCCCCCCCCCHHHHH | 31.67 | 30266825 | |
512 | Phosphorylation | SRSSDAFTTQHALRQ CCCCCCHHHHHHHHH | 27.54 | 26074081 | |
513 | Phosphorylation | RSSDAFTTQHALRQA CCCCCHHHHHHHHHH | 16.35 | 26074081 | |
523 | Phosphorylation | ALRQAQMSKELVELN HHHHHHHHHHHHHHH | 15.76 | 26074081 | |
542 | Sumoylation | LKEALARKMTQNDSQ HHHHHHHHHCCCCHH | 40.46 | - | |
542 | Sumoylation | LKEALARKMTQNDSQ HHHHHHHHHCCCCHH | 40.46 | - | |
542 | Ubiquitination | LKEALARKMTQNDSQ HHHHHHHHHCCCCHH | 40.46 | - | |
544 | Phosphorylation | EALARKMTQNDSQLQ HHHHHHHCCCCHHCC | 27.53 | 22817900 | |
548 | Phosphorylation | RKMTQNDSQLQPIQY HHHCCCCHHCCCCEE | 40.10 | 27282143 | |
593 | Acetylation | KKDANQAKLSERRRK HHHHHHHHHHHHHHH | 42.66 | 23236377 | |
595 | Phosphorylation | DANQAKLSERRRKRL HHHHHHHHHHHHHHH | 28.49 | 23532336 | |
624 | Acetylation | NEQSKLLKLKESTER HHHHHHHHHHHHHHH | 68.87 | 2402993 | |
632 | Phosphorylation | LKESTERTVSKLNQE HHHHHHHHHHHHHHH | 23.93 | 22617229 | |
634 | Phosphorylation | ESTERTVSKLNQEIR HHHHHHHHHHHHHHH | 30.71 | 22617229 | |
635 | Acetylation | STERTVSKLNQEIRM HHHHHHHHHHHHHHH | 47.31 | 25953088 | |
635 | Ubiquitination | STERTVSKLNQEIRM HHHHHHHHHHHHHHH | 47.31 | - | |
670 | Ubiquitination | QWKQKKDKEVIQLKE HHHHHCCHHHHHHHH | 63.86 | - | |
676 | Ubiquitination | DKEVIQLKERDRKRQ CHHHHHHHHHHHHHH | 34.04 | - | |
684 | Phosphorylation | ERDRKRQYELLKLER HHHHHHHHHHHHHHH | 16.75 | 28152594 | |
688 | Ubiquitination | KRQYELLKLERNFQK HHHHHHHHHHHHHHH | 62.01 | - | |
715 | Ubiquitination | AAANKRLKDALQKQR HHHHHHHHHHHHHHH | 45.01 | - | |
772 | Sumoylation | NDLLEDRKILAQDVA HHHHHHHHHHHHHHH | 55.16 | - | |
772 | Sumoylation | NDLLEDRKILAQDVA HHHHHHHHHHHHHHH | 55.16 | - | |
782 | Ubiquitination | AQDVAQLKEKKESGE HHHHHHHHHHHHCCC | 56.24 | - | |
787 | Phosphorylation | QLKEKKESGENPPPK HHHHHHHCCCCCCCH | 61.35 | 22985185 | |
799 | Phosphorylation | PPKLRRRTFSLTEVR CCHHHHHEEEEEEEE | 18.76 | 22167270 | |
801 | Phosphorylation | KLRRRTFSLTEVRGQ HHHHHEEEEEEEECC | 33.49 | 19664994 | |
803 | Phosphorylation | RRRTFSLTEVRGQVS HHHEEEEEEEECCCC | 31.10 | 30266825 | |
810 | Phosphorylation | TEVRGQVSESEDSIT EEEECCCCCCHHHHH | 27.76 | 22167270 | |
812 | Phosphorylation | VRGQVSESEDSITKQ EECCCCCCHHHHHHH | 38.92 | 22167270 | |
815 | Phosphorylation | QVSESEDSITKQIES CCCCCHHHHHHHHHH | 28.27 | 29255136 | |
817 | Phosphorylation | SESEDSITKQIESLE CCCHHHHHHHHHHHH | 22.35 | 29255136 | |
822 | Phosphorylation | SITKQIESLETEMEF HHHHHHHHHHHHHHH | 32.89 | 27174698 | |
825 | Phosphorylation | KQIESLETEMEFRSA HHHHHHHHHHHHHHH | 46.02 | 27174698 | |
840 | Ubiquitination | QIADLQQKLLDAESE HHHHHHHHHHHCCCC | 37.75 | 21890473 | |
840 (in isoform 1) | Ubiquitination | - | 37.75 | 21890473 | |
840 (in isoform 2) | Ubiquitination | - | 37.75 | 21890473 | |
851 | Ubiquitination | AESEDRPKQRWENIA CCCCCCHHHHHHHHH | 54.08 | - | |
868 | Acetylation | LEAKCALKYLIGELV HHHHHHHHHHHHHHH | 21.34 | 19608861 | |
869 | Phosphorylation | EAKCALKYLIGELVS HHHHHHHHHHHHHHH | 12.38 | 20068231 | |
876 | Phosphorylation | YLIGELVSSKIQVSK HHHHHHHHCCHHHHH | 38.24 | 20068231 | |
877 | Phosphorylation | LIGELVSSKIQVSKL HHHHHHHCCHHHHHH | 26.71 | 20068231 | |
883 | Acetylation | SSKIQVSKLESSLKQ HCCHHHHHHHHHHHH | 58.37 | 23236377 | |
883 | Ubiquitination | SSKIQVSKLESSLKQ HCCHHHHHHHHHHHH | 58.37 | - | |
893 | Phosphorylation | SSLKQSKTSCADMQK HHHHHCCCCHHHHHH | 33.99 | - | |
894 | Phosphorylation | SLKQSKTSCADMQKM HHHHCCCCHHHHHHH | 15.85 | - | |
900 | Acetylation | TSCADMQKMLFEERN CCHHHHHHHHHHHHC | 30.82 | 25953088 | |
930 | Acetylation | MEQQHQEKVLYLLSQ HHHHHHHHHHHHHHH | 30.85 | 26051181 | |
941 | Phosphorylation | LLSQLQQSQMAEKQL HHHHHHHHHHHHHHH | 14.68 | 27050516 | |
946 | Ubiquitination | QQSQMAEKQLEESVS HHHHHHHHHHHHHHH | 51.12 | - | |
951 | Phosphorylation | AEKQLEESVSEKEQQ HHHHHHHHHHHHHHH | 22.90 | 30266825 | |
953 | Phosphorylation | KQLEESVSEKEQQLL HHHHHHHHHHHHHHH | 52.83 | 30266825 | |
955 | Acetylation | LEESVSEKEQQLLST HHHHHHHHHHHHHHH | 54.00 | 26051181 | |
955 | Ubiquitination | LEESVSEKEQQLLST HHHHHHHHHHHHHHH | 54.00 | 21890473 | |
955 (in isoform 1) | Ubiquitination | - | 54.00 | 21890473 | |
955 (in isoform 2) | Ubiquitination | - | 54.00 | 21890473 | |
961 | Phosphorylation | EKEQQLLSTLKCQDE HHHHHHHHHHCCCHH | 40.04 | 21712546 | |
962 | Phosphorylation | KEQQLLSTLKCQDEE HHHHHHHHHCCCHHH | 30.15 | 24732914 | |
964 | Ubiquitination | QQLLSTLKCQDEELE HHHHHHHCCCHHHHH | 29.91 | - | |
993 | Acetylation | ENEIIKQKLTLLQVA HCHHHHHHHHHHHHH | 38.14 | 25953088 | |
993 | Ubiquitination | ENEIIKQKLTLLQVA HCHHHHHHHHHHHHH | 38.14 | - | |
995 | Phosphorylation | EIIKQKLTLLQVASR HHHHHHHHHHHHHHH | 32.24 | 18318008 | |
1001 | Phosphorylation | LTLLQVASRQKHLPK HHHHHHHHHCCCCCC | 36.07 | 25159151 | |
1010 | Phosphorylation | QKHLPKDTLLSPDSS CCCCCCCCCCCCCCC | 35.41 | 17081983 | |
1013 | Phosphorylation | LPKDTLLSPDSSFEY CCCCCCCCCCCCCCC | 29.76 | 25159151 | |
1016 | Phosphorylation | DTLLSPDSSFEYVPP CCCCCCCCCCCCCCC | 40.07 | 25159151 | |
1017 | Phosphorylation | TLLSPDSSFEYVPPK CCCCCCCCCCCCCCC | 29.49 | 25159151 | |
1020 | Phosphorylation | SPDSSFEYVPPKPKP CCCCCCCCCCCCCCC | 19.08 | 21712546 | |
1028 | Phosphorylation | VPPKPKPSRVKEKFL CCCCCCCCHHHHHHH | 56.69 | 30108239 | |
1031 | Acetylation | KPKPSRVKEKFLEQS CCCCCHHHHHHHHHC | 54.82 | 25953088 | |
1038 | Phosphorylation | KEKFLEQSMDIEDLK HHHHHHHCCCHHHHH | 14.73 | 29255136 | |
1039 | Sulfoxidation | EKFLEQSMDIEDLKY HHHHHHCCCHHHHHH | 6.34 | 21406390 | |
1046 | Phosphorylation | MDIEDLKYCSEHSVN CCHHHHHHHHHCCCC | 14.43 | 23663014 | |
1048 | Phosphorylation | IEDLKYCSEHSVNEH HHHHHHHHHCCCCCC | 34.94 | 22617229 | |
1051 | Phosphorylation | LKYCSEHSVNEHEDG HHHHHHCCCCCCCCC | 23.68 | 22617229 | |
1071 | Sumoylation | EGDDEEWKPTKLVKV CCCCCCCCCEEEEEE | 46.20 | - | |
1095 | Ubiquitination | CKGWCGNKQCGCRKQ CCCCCCCCCCCCCCC | 32.05 | - | |
1104 | Phosphorylation | CGCRKQKSDCGVDCC CCCCCCCCCCCCCCC | 35.32 | 28258704 | |
1115 | Phosphorylation | VDCCCDPTKCRNRQQ CCCCCCCHHHCCCCC | 29.53 | 28258704 | |
1126 | Phosphorylation | NRQQGKDSLGTVERT CCCCCCCCCCCCEEC | 31.98 | 25159151 | |
1129 | Phosphorylation | QGKDSLGTVERTQDS CCCCCCCCCEECCCC | 25.20 | 24732914 | |
1133 | Phosphorylation | SLGTVERTQDSEGSF CCCCCEECCCCCCCE | 24.19 | 22617229 | |
1136 | Phosphorylation | TVERTQDSEGSFKLE CCEECCCCCCCEECC | 33.76 | 21712546 | |
1139 | Phosphorylation | RTQDSEGSFKLEDPT ECCCCCCCEECCCCC | 18.37 | 25159151 | |
1146 | Phosphorylation | SFKLEDPTEVTPGLS CEECCCCCCCCCCCC | 56.24 | 23663014 | |
1149 | Phosphorylation | LEDPTEVTPGLSFFN CCCCCCCCCCCCCCC | 12.85 | 23663014 | |
1153 | Phosphorylation | TEVTPGLSFFNPVCA CCCCCCCCCCCCCCC | 33.44 | 29255136 | |
1161 | Phosphorylation | FFNPVCATPNSKILK CCCCCCCCCCHHHHH | 20.20 | 29255136 | |
1164 | Phosphorylation | PVCATPNSKILKEMC CCCCCCCHHHHHHHC | 23.44 | 29255136 | |
1178 | Phosphorylation | CDVEQVLSKKTPPAP CCHHHHHCCCCCCCC | 33.00 | 21815630 | |
1181 | Phosphorylation | EQVLSKKTPPAPSPF HHHHCCCCCCCCCCC | 37.94 | 29255136 | |
1186 | Phosphorylation | KKTPPAPSPFDLPEL CCCCCCCCCCCCHHH | 40.06 | 22167270 | |
1194 | Sumoylation | PFDLPELKHVATEYQ CCCCHHHHHHHHHHH | 34.08 | 28112733 | |
1198 | Phosphorylation | PELKHVATEYQENKA HHHHHHHHHHHHCCC | 33.85 | 26074081 | |
1200 | Phosphorylation | LKHVATEYQENKAPG HHHHHHHHHHCCCCC | 19.44 | 26074081 | |
1216 | Phosphorylation | KKKRALASNTSFFSG HHHHHHHCCCCCCCC | 41.30 | 22167270 | |
1218 | Phosphorylation | KRALASNTSFFSGCS HHHHHCCCCCCCCCC | 25.15 | 22167270 | |
1219 | Phosphorylation | RALASNTSFFSGCSP HHHHCCCCCCCCCCC | 28.66 | 22167270 | |
1222 | Phosphorylation | ASNTSFFSGCSPIEE HCCCCCCCCCCCCCC | 36.56 | 22167270 | |
1225 | Phosphorylation | TSFFSGCSPIEEEAH CCCCCCCCCCCCCCC | 32.22 | 22167270 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
799 | T | Phosphorylation | Kinase | AURA | O14965 | PSP |
799 | T | Phosphorylation | Kinase | AURKB | Q96GD4 | GPS |
801 | S | Phosphorylation | Kinase | PRKAA1 | Q13131 | GPS |
801 | S | Phosphorylation | Kinase | AURB | Q96GD4 | PSP |
1161 | T | Phosphorylation | Kinase | CDK1 | P06493 | PSP |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of KIF4A_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of KIF4A_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
HM20B_HUMAN | HMG20B | physical | 12809554 | |
BRCA2_HUMAN | BRCA2 | physical | 18604178 | |
PRC1_HUMAN | PRC1 | physical | 15297875 | |
A4_HUMAN | APP | physical | 21832049 | |
ARP6_HUMAN | ACTR6 | physical | 26344197 | |
GBF1_HUMAN | GBF1 | physical | 26344197 | |
ZPR1_HUMAN | ZPR1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394; SER-801; SER-1001AND SER-1038, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-801; THR-1161 ANDSER-1225, AND MASS SPECTROMETRY. | |
"Large-scale phosphoproteome analysis of human liver tissue byenrichment and fractionation of phosphopeptides with strong anionexchange chromatography."; Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,Zou H., Gu J.; Proteomics 8:1346-1361(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-995 AND SER-1001, ANDMASS SPECTROMETRY. | |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-799; SER-801; SER-951;SER-1001; SER-1013; SER-1016; SER-1017; TYR-1020; SER-1028; THR-1181;SER-1186 AND SER-1225, AND MASS SPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394; SER-501; SER-810;SER-815; SER-1126 AND THR-1129, AND MASS SPECTROMETRY. | |
"Phosphoproteome analysis of the human mitotic spindle."; Nousiainen M., Sillje H.H.W., Sauer G., Nigg E.A., Koerner R.; Proc. Natl. Acad. Sci. U.S.A. 103:5391-5396(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-507; SER-801; SER-810;SER-951; SER-1013; SER-1017; SER-1038; SER-1126; THR-1161; THR-1181;SER-1186 AND SER-1225, AND MASS SPECTROMETRY. | |
"A probability-based approach for high-throughput proteinphosphorylation analysis and site localization."; Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.; Nat. Biotechnol. 24:1285-1292(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-801 AND THR-1181, ANDMASS SPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-394; THR-544; THR-799;SER-801; THR-1010; SER-1013; SER-1016; SER-1038; SER-1048; SER-1051AND SER-1225, AND MASS SPECTROMETRY. |